Renal function and cardiovascular risk in patients with essential hypertension. The «FRESHA» study;Función renal y riesgo cardiovascular en pacientes con hipertensión arterial esencial. Estudio FRESHA

Nefrologia

Volumn 26, Issue 3, 2006, Pages 330-338

  Herrero, Pablo ^a   Marin R ^a   Fernandez Vega F ^a   Gorostidi, M ^b   Riesgo, A ^a   Vazquez J ^a   Diez Ojea B ^c  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL SAN AGUSTÍN   (Spain)

^c NONE

Author keywords

Cardiovascular risk; Essential hypertension; Estimated renal function; Renal disease

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33750600146     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H y cols.: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12: 218-25, 2001.
2. Schillaci G, Reboldi G, Verdecchia P: High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension (The PIUMA Study). Arch Intern Med 161: 886-91, 2001.
3. Wang JG, Staessen JA, Fagard RH, Birkenhäger WH, Gong L, Liu L y cols.: Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37: 1069-74, 2001.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL y cols.: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-52, 2003.
5. Gorostidi M, Marín R: Nefropatía vascular. Concepto y significado. Epidemiología. Hipertensión arterial esencial e insuficiencia renal. Nefroesclerosis, nefropatía isquémica o aterosclerótica. Nefrología 24 (Supl. 6): 73-83, 2004.
6. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL y cols.: Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108: 2154-69, 2003.
7. National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (Supl. 1): S1-S266, 2002.
8. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW y cols.: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-47, 2003.
9. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976.
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 130: 461-70, 1999.
11. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M y cols.: Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 42: 14-8, 2003.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (Supl. 1): S5-10, 2004.
13. Marín R, De la Sierra A, Armario P, Banegas JR, Campo C, Gorostidi M: Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España. Med Clin (Barc) 125: 24-34, 2005.
14. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17: 863-71, 1916.
15. Aranda P, Ruilope LM, Marín R, Aljama P, Luque M: Estudio transversal sobre prevalencia de insuficiencia renal en la hipertensión arterial esencial. Estudio Laennec. Nefrología 15: 134-40, 1995.
16. Olivares J, Guillén F, Sánchez JJ, Morales FJ: Influencia de la presión arterial y la edad en la función renal. Estudio «Cuidar el riñón». Nefrología 23: 137-44, 2003.
17. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL y cols.: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-95, 2004.
18. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-36, 2001.
19. Weiner DE, Tighiouart H, Stark PC, Amin MC, MacLeod B, Griffith JL y cols.: Kidney disease as a risk factor to recurrent cardiovascular disease and mortality. Am J Kidney Dis 44: 198-206, 2004.
20. Ronald MA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ y cols.: Mild renal insufficiency is associated with increased cardiovascular mortality: HOORN Study: Kidney Int 62: 1402-7, 2002.
21. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C y cols.: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293: 1737-45, 2005.
22. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med 351: 1296-305, 2004.
23. Clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (Supl. 3): S1-S153, 2005.
24. Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Vaccaro V, y cols.: Creatinine clearance and signs of end-organ damage in primary hypertension. J Hum Hypertens 18: 511-6, 2004.
25. Hailpern SM, Cohen HW, Alderman MH: Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens 23: 1809-16, 2005.
26. Swedko PJ, Clark HD, Paramsothy K, Akbari A: Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 163: 356-60, 2003.
27. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16: 763-73, 2005.
28. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A: Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 46: 233-41, 2005.
29. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adults US population: third national health and nutrition examination survey. Am J Kidney Dis 41: 1-12, 2003.
30. Gallego E, Lopez A, Lorenzo I, Lopez E, Llamas F, Illescas ML y cols.: Referencia precoz y tardía al nefrólogo; su influencia en la morbimortalidad en hemodiálisis. Nefrología 23: 234-42, 2003.
31. Tranche S, Riesgo A, Marín R, Díaz González G, García Fernández A: Prevalencia de insuficiencia renal «oculta» en población diabética tipo 2. Aten Primaria 35: 359-64, 2005.
32. Gorostidi M, Marín R: Tratamiento de la hipertensión arterial en pacientes con insuficiencia renal. Estadios 2 y 3 de la enfermedad renal crónica. Nefrología 24 (Supl. 6): 91-100, 2004.